Dual biologic therapy in the first-line mCRC setting: Implications of the CAIRO2 study

Research output: Contribution to journal › Editorial › peer-review

ASJC Scopus subject areas

@article{6ffaa7c0a94e4335846a2266af54a2af,

title = "Dual biologic therapy in the first-line mCRC setting: Implications of the CAIRO2 study",

author = "Edward Chu",

year = "2008",

month = jul,

doi = "10.3816/CCC.2008.n.030",

language = "English (US)",

volume = "7",

pages = "226",

journal = "Clinical colorectal cancer",

issn = "1533-0028",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - Dual biologic therapy in the first-line mCRC setting

T2 - Implications of the CAIRO2 study

AU - Chu, Edward

PY - 2008/7

Y1 - 2008/7

UR - http://www.scopus.com/inward/record.url?scp=49149089743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49149089743&partnerID=8YFLogxK

U2 - 10.3816/CCC.2008.n.030

DO - 10.3816/CCC.2008.n.030

M3 - Editorial

C2 - 18650190

AN - SCOPUS:49149089743

SN - 1533-0028

VL - 7

SP - 226

JO - Clinical colorectal cancer

JF - Clinical colorectal cancer

IS - 4

ER -